Elutia, Inc. (ELUT)
1.16
+0.04
(+3.57%)
USD |
NASDAQ |
May 29, 16:00
1.16
0.00 (0.00%)
After-Hours: 20:00
Elutia EPS Diluted (Quarterly) : -0.1836 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | -0.3737 |
| MiMedx Group, Inc. | -0.0732 |
| Agenus, Inc. | 1.023 |
| Amgen, Inc. | 3.344 |
| BioCryst Pharmaceuticals, Inc. | -2.980 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.894M |
| Revenue (Quarterly) | 3.114M |
| Total Expenses (Quarterly) | 11.01M |
| Enterprise Value | 34.39M |
| Gross Profit Margin (Quarterly) | 57.87% |
| Profit Margin (Quarterly) | -253.5% |
| Earnings Yield | -65.39% |
| Normalized Earnings Yield | -63.32 |